| Company
| Aggregate Score
| P/E ratio
| Gross margin
| EBIT margin
| ROA
| Net income per employee
|
| Deciphera Pharmaceuticals, Inc.
|
| -12
| 96.0%
| -118.1%
| -45.2%
| -€465.41K
|
| PolyPeptide Group AG
|
| -24
| 11.3%
| -2.3%
| -4.5%
| -€25.49K
|
| Dermapharm Holding SE
|
| 18
| 65.7%
| 18.5%
| 5.0%
| €29.70K
|
| Biofrontera AG
|
| -17
| 80.6%
| 14.8%
| -1.2%
| -€4.05K
|
| Neurocrine Biosciences, Inc.
|
| 28
| 98.4%
| 20.5%
| 10.0%
| €206.31K
|
| Supernus Pharmaceuticals, Inc.
|
| -96
| 78.4%
| -5.6%
| -1.3%
| -€24.61K
|
| Ironwood Pharmaceuticals, Inc.
|
| 3.9
| 99.7%
| 36.9%
| 7.4%
| €101.11K
|
| Lifecore Biomedical, Inc.
|
| -7.6
| 31.6%
| -18.9%
| -13.8%
| -€53.78K
|
| AB Science S.A.
|
| -9
| 54.2%
| -661.6%
| -33.8%
| -€195.78K
|
| Zoetis Inc.
|
| 28
| 71.0%
| 37.6%
| 17.5%
| €166.68K
|
| Shield Therapeutics plc
|
| -0.016
| 44.6%
| -35.3%
| -26.4%
| -€298.72K
|
| Swedencare AB (publ)
|
| 113
| 43.8%
| 6.4%
| 0.7%
| €9.80K
|
| Boiron SA
|
| 21
| 73.7%
| 9.3%
| 3.4%
| €7.84K
|
| Aytu BioPharma, Inc.
|
| -0.9
| 67.6%
| -13.2%
| -10.5%
| -€111.19K
|
| Apontis Pharma AG
|
| 137
| 25.3%
| -0.0%
| 1.5%
| €4.78K
|
| Eagle Pharmaceuticals, Inc.
|
| 1.9
| 69.8%
| 9.2%
| 3.8%
| €100.79K
|
| Shionogi & Co., Ltd.
|
| 12
| 85.5%
| 37.5%
| 11.6%
| €196.56K
|
| Dr. Reddy's Laboratories Limited
|
| 20
| 57.7%
| 21.4%
| 10.9%
| €19.57K
|
| ECO Animal Health Group plc
|
| 0.25
| 45.1%
| 5.3%
| 1.4%
| €8.51K
|
| Intra-Cellular Therapies, Inc.
|
| -187
| 91.6%
| -17.1%
| -5.5%
| -€75.34K
|
| Allergy Therapeutics plc
|
| -0.096
| 54.0%
| -54.1%
| -48.9%
| -€66.76K
|
| Evolus, Inc.
|
| -11
| 65.9%
| -13.7%
| -26.7%
| -€136.59K
|
| Aspen Pharmacare Holdings Limited
|
| -848
| 44.1%
| 7.1%
| -0.8%
| -€6.23K
|
| SCYNEXIS, Inc.
|
| -1.4
| 53.5%
| -1,181.1%
| -49.5%
| -€784.01K
|
| PLx Pharma Inc.
|
| -0.17
| 4.5%
| -880.5%
| -45.6%
| -€821.29K
|
| Fagron NV
|
| 19
| 45.7%
| 15.3%
| 7.7%
| €22.38K
|
| Almirall, S.A.
|
| 110
| 78.1%
| 4.9%
| 0.9%
| €10.53K
|
| HUTCHMED (China) Limited
|
| 6.6
| 8.9%
| -3.3%
| 26.3%
| €223.69K
|
| Elanco Animal Health Incorporated
|
| 195
| 49.2%
| 5.2%
| 0.3%
| €3.47K
|
| Evotec SE
|
| -8.5
| 10.8%
| -11.3%
| -9.0%
| -€33.36K
|
| Siegfried Holding AG
|
| 29
| 25.7%
| 15.2%
| 7.8%
| €43.04K
|
| Mithra Pharmaceuticals SA
|
| -0.083
| 14.9%
| -173.9%
| -60.5%
| -€642.60K
|
| Collegium Pharmaceutical, Inc.
|
| 16
| 57.2%
| 20.9%
| 3.6%
| €142.04K
|
| Sumitomo Pharma Co., Ltd.
|
| 3.4K
| 60.9%
| 12.6%
| 2.6%
| €20.64K
|
| Green Thumb Industries Inc.
|
| 20
| 51.1%
| 15.2%
| 1.7%
| €7.73K
|
| MERCK Kommanditgesellschaft auf Aktien
|
| 15
| 58.5%
| 18.0%
| 6.0%
| €48.51K
|
| Lantheus Holdings, Inc.
|
| 33
| 62.2%
| 22.8%
| 7.4%
| €180.07K
|
| Ipsen S.A.
|
| 16
| 83.3%
| 16.8%
| 6.6%
| €83.59K
|
| Mountain Valley MD Holdings Inc.
|
| -0.96
| -26.5%
| -5,608.2%
| -272.4%
| €0.00
|
| Dynavax Technologies Corporation
|
| -28
| 83.2%
| 3.2%
| -4.6%
| -€92.98K
|
| Vetoquinol SA
|
| 14
| 34.6%
| 14.2%
| 8.3%
| €23.80K
|
| ANI Pharmaceuticals, Inc.
|
| 36
| 55.6%
| 7.1%
| 2.6%
| €36.05K
|
| Viatris Inc.
|
| -2.9
| 36.1%
| -18.4%
| -9.7%
| -€100.09K
|
| Takeda Pharmaceutical Company Limited
|
| 209
| 64.6%
| 5.6%
| 0.2%
| €3.64K
|
| Tilray Brands, Inc.
|
| -0.2
| 28.7%
| -235.1%
| -102.9%
| -€701.65K
|
| Athenex, Inc.
|
| -0.022
| 23.0%
| -61.7%
| -50.4%
| -€331.87K
|
| CV Sciences, Inc.
|
| -3.2
| 60.8%
| -9.4%
| -21.1%
| -€27.29K
|
| Hikma Pharmaceuticals PLC
|
| 17
| 41.7%
| 15.4%
| 6.7%
| €33.76K
|
| Aerie Pharmaceuticals, Inc.
|
| 0
| 89.0%
| -10.9%
| -9.7%
| -€84.36K
|
| Trees Corporation
|
| -0.68
| 42.6%
| -5.1%
| -20.0%
| -€39.60K
|
| PetIQ, Inc.
|
| 69
| 24.6%
| 5.7%
| 1.5%
| €10.21K
|
| Sonoma Pharmaceuticals, Inc.
|
| -1.5
| 37.7%
| -18.4%
| -25.1%
| -€301.87K
|
| Eisai Co., Ltd.
|
| 24
| 78.3%
| 6.8%
| 3.4%
| €24.25K
|
| Alliance Pharma plc
|
| -0.33
| 55.7%
| 15.9%
| -2.9%
| -€42.40K
|
| Organogenesis Holdings Inc.
|
| -235
| 73.1%
| -1.8%
| -0.3%
| -€1.74K
|
| Esperion Therapeutics, Inc.
|
| -2.4
| 56.2%
| -7.1%
| -26.9%
| -€279.42K
|
| Sandoz Group AG
|
| 101
| 46.6%
| 17.5%
| 1.1%
| €8.93K
|
| Teva Pharmaceutical Industries Limited
|
| 27
| 50.1%
| 10.9%
| 1.8%
| €16.70K
|
| Emergent BioSolutions Inc.
|
| 4.7
| 49.9%
| 15.1%
| 5.2%
| €73.17K
|
| China Shineway Pharmaceutical Group Limited
|
| 39
| 75.1%
| 21.5%
| 10.1%
| €37.88K
|
| Cosmos Health Inc.
|
| -0.93
| 9.8%
| -26.7%
| -24.9%
| -€89.52K
|
| Biostar Pharmaceuticals, Inc.
|
| 0.00028
| -11.6%
| 876.7%
| 2.3%
| €4.06K
|
| VIVO Cannabis Inc.
|
| -0.19
| 17.1%
| -15.4%
| -106.6%
| -€194.85K
|
| Swedish Orphan Biovitrum AB (publ)
|
| 7.9K
| 51.3%
| 24.6%
| 0.0%
| €626.61
|
